19 investors have funded 10 Life Sciences companies head-officed in York, across 30 rounds (Jul 2006 – Oct 2025). They are ranked by how many York companies in this market they have actually backed.
"In York" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | White Rose Technology Seedcorn Fund | Glasgow, United Kingdom | Seed | 2 | 4 | — | Jan 2012 | 3 |
| 2 | Yorkshire Cancer Research | Harrogate, United Kingdom | Seed | 2 | 3 | — | Jan 2012 | 2 |
| 3 | Mercia | Henley in Arden, United Kingdom | Series A | 2 | 2 | 2 | Feb 2019 | 247 |
| 4 | Imperial Innovations | London, United Kingdom | Series A | 1 | 5 | 5 | Jul 2016 | 56 |
| 5 | Enterprise Ventures | Preston, United Kingdom | Series ASeed | 1 | 2 | — | Oct 2015 | 37 |
| 6 | Northstar Ventures | Newcastle Upon Tyne, United Kingdom | Seed | 1 | 1 | 1 | Apr 2007 | 133 |
| 7 | Finance Yorkshire | Barnsley, United Kingdom | Seed | 1 | 1 | — | Jan 2012 | 67 |
| 8 | NVM | Newcastle Upon Tyne, United Kingdom | PE | 1 | 1 | — | Jul 2022 | 57 |
| 9 | Braveheart Investment Group | Barnsley, United Kingdom | Seed | 1 | 1 | 1 | Jul 2016 | 16 |
| 10 | DSW Ventures | Manchester, United Kingdom | Seed | 1 | 1 | 1 | Jan 2024 | 18 |
| 11 | Acceleris Capital | Manchester, United Kingdom | Seed | 1 | 1 | 1 | Apr 2007 | 9 |
| 12 | South Yorkshire Investment Fund | Barnsley, United Kingdom | Seed | 1 | 1 | 1 | Jun 2007 | 12 |
| 13 | Meneldor | Druten, Netherlands | Series A | 1 | 1 | 1 | Jun 2018 | 6 |
| 14 | Seneca EIS Portfolio Fund | Haydock, United Kingdom | Post-IPO | 1 | 1 | 1 | Feb 2016 | 9 |
| 15 | Deeptech Seed Fund | Dublin, Ireland | Seed | 1 | 1 | 1 | Oct 2025 | 4 |
| 16 | York Angels | Seed | 1 | 1 | — | Oct 2025 | 2 | |
| 17 | Turner Pope Investments | London, United Kingdom | Post-IPO | 1 | 1 | — | Jul 2024 | 2 |
| 18 | Stargate Capital | Edgware, United Kingdom | Seed | 1 | 1 | 1 | Apr 2007 | 1 |
| 19 | SPARK Advisory Partners | London, United Kingdom | Post-IPO | 1 | 1 | — | Jul 2024 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in York that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Femeda femeda.com |
5 | 6 | $15.4M | Series A Feb 2019 |
| Aptamer Group aptamergroup.com |
3 | 3 | $9.5M | Post-IPO Jul 2024 |
| Cizzle Biotechnology cizzlebiotechnology.com |
3 | 6 | $4.8M | Seed Jan 2012 |
| Abingdon Health abingdonhealth.com |
2 | 6 | $22.6M | Series A Jan 2019 |
| Pro-Cure Therapeutics pro-cure.uk.com |
2 | 2 | $1.7M | Seed Nov 2007 |
| Kirkstall kirkstall.com |
2 | 2 | $323.7K | Seed Jul 2016 |
| MORF morf-bio.com |
2 | 2 | — | Seed Oct 2025 |
| YorkTest yorktest.com |
1 | 1 | $12M | PE Jul 2022 |
| Mesenbio mesenbio.net |
1 | 1 | $1.8M | Seed Jan 2024 |
| OptiBiotix Health optibiotix.com |
1 | 1 | $1.5M | Post-IPO Feb 2016 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Oct 2025 | York Angels | MORF | Seed | — |
| Oct 2025 | Deeptech Seed FundLED | MORF | Seed | — |
| Jul 2024 | SPARK Advisory Partners | Aptamer Group | Post-IPO | $3.7M |
| Jul 2024 | Turner Pope Investments | Aptamer Group | Post-IPO | $3.7M |
| Jan 2024 | DSW VenturesLED | Mesenbio | Seed | $1.8M |
| Jul 2022 | NVM | YorkTest | PE | $12M |
| Feb 2019 | MerciaLED | Femeda | Series A | $5.2M |
| Jan 2019 | MerciaLED | Abingdon Health | Series A | $2.6M |
| Jun 2018 | MeneldorLED | Aptamer Group | Series A | $2.2M |
| Jul 2016 | Imperial InnovationsLED | Abingdon Health | Series A | $3.9M |
| Jul 2016 | Braveheart Investment GroupLED | Kirkstall | Seed | $323.7K |
| Feb 2016 | Seneca EIS Portfolio FundLED | OptiBiotix Health | Post-IPO | $1.5M |
| Oct 2015 | Enterprise Ventures | Femeda | Series A | — |
| Jun 2015 | Imperial InnovationsLED | Abingdon Health | Series A | $4.7M |
| Oct 2014 | Imperial InnovationsLED | Abingdon Health | Series A | $3.4M |
| May 2012 | Imperial InnovationsLED | Abingdon Health | Series A | $4.8M |
| Mar 2012 | Imperial InnovationsLED | Abingdon Health | Series A | $3.2M |
| Jan 2012 | Yorkshire Cancer Research | Cizzle Biotechnology | Seed | $858.4K |
| Jan 2012 | White Rose Technology Seedcorn Fund | Cizzle Biotechnology | Seed | $858.4K |
| Jan 2012 | Finance Yorkshire | Cizzle Biotechnology | Seed | $858.4K |
Life Sciences investors in other cities